Medtronic issues recall for MiniMed insulin pumps
Medtronic recalls Minimed insulin pumps for reduced battery life
The company said it received 170 reports of hyperglycemia and 11 reports of diabetic ketoacidosis in the U.S. that could be linked to the problem.
Medtronic voluntary recalls MiniMed 600 series or 700 series insulin pumps due to potential risks of shortened pump battery life
Galway: Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed 600 series or 700 series insulin pumps to follow their pump's
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life
Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life.
Medtronic issues recall for MiniMed insulin pumps over battery issues
Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the issue has revealed that the devices may experience shortened battery life if they are dropped,
Medtronic shares dip after FDA tags insulin pump recall as Class I
Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.
Medtronic Recalls MiniMed Pump Due To Battery Life Concerns
Medtronic issued a recall on its MiniMed insulin pumps following reports of battery life issues that may lead to insulin delivery stoppages.
Medtronic Recalls MiniMed Insulin Pumps Over Battery Issues -- Update
The Dublin-based medical-device maker said Friday that customers of its MiniMed 600 series or 700 series insulin pumps have reported shortened battery life in pumps that have been dropped or experienced some kind of physical impact that damaged internal components.
Medtronic Recalls MiniMed 600/700 Series Insulin Pumps For Shortened Battery Life
Medtronic plc, an Irish healthcare technology company, is recalling its MiniMed 600 series or 700 series insulin pumps citing
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life
Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue
Hosted on MSN1d
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases an aging population suffers.
Medtronic: This Dividend Aristocrat Is Still A Buy Now
Discover why Medtronic is a top Dividend Aristocrat with strong financial performance and potential for 12% annual returns ...
Medtronic PLC stock rises Friday, still underperforms market
Shares of Medtronic PLC MDT inched 0.56% higher to $88.26 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and ...
KSTP-TV2d
St. Paul Art Crawl, Medtronic TC Marathon make for a busy weekend in the Twin Cities
The Medtronic TC Marathon, as well as the St. Paul Art Crawl will be bringing thousands of people to each event.
Is Medtronic plc (NYSE:MDT) The Top Goldman Sachs Fund Manager Stock Pick?
We recently made a list of Goldman Sachs’ Top Fund Manager Stock Picks: 25 Best Overweight Stocks. In this piece, we will ...
Zacks.com on MSN6d
Reasons to Retain Medtronic Stock in Your Portfolio Now
Medtronic plc’s MDT growth is backed by remarkable progress within the Neurosurgery Portfolio. The company’s continuous ...
GI Alliance Collaborates with Medtronic to Introduce GI Genius™ AI Technology for Enhanced Colon Polyp Detection
The Medtronic GI Genius™ system demonstrates AI's capacity to improve diagnostic accuracy by serving as a second set of eyes for clinicians, demonstrating 99.7%-100% sensitivity rate when screening ...
MassDevice4d
The top 10 neurotech stories of the year so far
Across medtech, companies have continued to innovate through the first nine months of 2024, and that rings especially true in ...